Asthma Clinical Trial
Official title:
Developing a National Learning Health System for Asthma to Reduce the Risk of Asthma Attacks and the Risk of Asthma Hospitalisations and Deaths
This study forms an initial phase of work aimed at developing a learning health system
(LHS), whereby data relating to asthma is extracted from patient electronic health records
(EHRs) across Scotland, analysed to explore variations in clinical practice and then shared
with general practices to highlight any improvements that can be made so that they can
better support people with asthma.
If successful, the investigators hope to progress to the main quality improvement phase
involving an increased number of practices and then incrementally build this up to cover the
whole of Scotland.
The UK has amongst the highest rates of asthma in the world as well as some of the poorest
health outcomes from asthma.
Investigations into asthma deaths in the UK have found that the way patients were managed in
the time leading up to their death could be improved significantly and half of asthma deaths
are potentially avoidable. For most people with asthma, symptoms can come and go and
sometimes be erratic. To prevent these symptoms, there is a window of opportunity to
intervene with the appropriate care. This window occurs between when someone experiences
early symptoms like night cough or wheeze and when they experience a full-blown asthma
attack.
Most people with asthma receive care primarily in their general practice. General practices
have a history of using health information technology to care for their patients. The use of
this technology over time has resulted in the creation of rich electronic healthcare data.
Through this rich data there are opportunities to create a system whereby clinical
management can be benchmarked and improvements highlighted.
This study forms an initial phase of work aimed at developing a learning health system
(LHS), whereby data relating to asthma is extracted from patient electronic health records
(EHRs) across Scotland, analysed to explore variations in clinical practice and then shared
with general practices to highlight any improvements that can be made so that they can
better support people with asthma.
If successful, the investigators hope to progress to the main quality improvement phase
involving an increased number of practices and then incrementally build this up to cover the
whole of Scotland.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
||
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|